Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1988 | 1 |
1990 | 1 |
1991 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy.
Immunol Rev. 1991 Jun;121:171-91. doi: 10.1111/j.1600-065x.1991.tb00828.x.
Immunol Rev. 1991.
PMID: 1937531
Review.
No abstract available.
Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative.
PelvEx Collaborative.
PelvEx Collaborative.
Colorectal Dis. 2020 Sep;22(9):1184-1188. doi: 10.1111/codi.15007. Epub 2020 Mar 2.
Colorectal Dis. 2020.
PMID: 32043753
Item in Clipboard
The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.
Ottenhoff TH, Ab BK, Van Embden JD, Thole JE, Kiessling R.
Ottenhoff TH, et al. Among authors: ab bk.
J Exp Med. 1988 Nov 1;168(5):1947-52. doi: 10.1084/jem.168.5.1947.
J Exp Med. 1988.
PMID: 2903217
Free PMC article.
Item in Clipboard
Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
Ab BK, Kiessling R, Van Embden JD, Thole JE, Kumararatne DS, Pisa P, Wondimu A, Ottenhoff TH.
Ab BK, et al.
Eur J Immunol. 1990 Feb;20(2):369-77. doi: 10.1002/eji.1830200221.
Eur J Immunol. 1990.
PMID: 1690136
Item in Clipboard
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro.
Hancock GE, Molloy A, Ab BK, Kiessling R, Becx-Bleumink M, Cohn ZA, Kaplan G.
Hancock GE, et al. Among authors: ab bk.
Cell Immunol. 1991 Feb;132(2):277-84. doi: 10.1016/0008-8749(91)90027-9.
Cell Immunol. 1991.
PMID: 1988157
Item in Clipboard
Cite
Cite